Aesthetic Medical International Announces Business Updates
02 December 2021 - 12:22AM
Aesthetic Medical International Holdings Group Limited (Nasdaq:
AIH) (the “Company” or “AIH”), a leading provider of aesthetic
medical services in China, today announces business updates for
November 2021.
Benefited from the Company’s successful
promotional events during the “Double 11 Online Shopping Festival”
and the Company’s 25th Anniversary Celebration promotions, the
Company expected that cash sales generated from its existing
hospitals and clinics in November would reach approximately RMB90
million, representing their monthly record high since the beginning
of 2020. As stated in the earning release published on November 16,
2021, the Company will continue to implement its strategic
restructuring plan to optimize business operations and launch
satellite clinics in the Company’s core regional markets.
The Company also noted that the regulators of
the People's Republic of China has strengthened the supervision of
the aesthetic medical industry and proposed various guidelines to
ensure the healthy development of the aesthetic medical industry.
Certain regulatory announcements included regulating advertisements
as well as cracking down illegal manufacturing and sales of the
aesthetic medical products. The Company will closely monitor the
regulatory development and strive to comply with applicable
regulations. The Company believes that these series of regulations
would not only foster the orderly development of the industry, but
also create a favorable operating environment for market players in
support of such regulatory reform, such as AIH.
About Aesthetic Medical International
Holdings Group Limited
AIH, known as “Peng’ai” in China, is a leading
provider of aesthetic medical services in China. AIH operates
through treatment centers that spread across major cities in
mainland China, and also has presence in Hong Kong and Singapore.
Leveraging over 20 years of clinical experience, AIH provides
one-stop aesthetic service offerings, including surgical aesthetic
treatments, non-surgical aesthetic treatments, general medical
services and other aesthetic services. According to a certain third
party industry consultant, AIH was the third-largest private
aesthetic medical services provider in China in terms of revenue in
2018. For more information regarding the Company, please visit:
https://ir.aihgroup.net/.
Safe Harbor Statement
This press release contains “forward-looking
statements.” These statements are made under the “safe harbor”
provisions of the U.S. Private Securities Litigation Reform Act of
1995. These forward-looking statements can be identified by
terminology such as “will,” “expects,” “anticipates,” “aims,”
“future,” “intends,” “plans,” “believes,” “estimates,” “likely to”
and similar statements. Statements that are not historical facts,
including statements about the Company’s beliefs, plans and
expectations, are forward-looking statements. Forward-looking
statements involve inherent risks and uncertainties. These risks
and uncertainties and others that relate to the Company’s business,
financial condition and industry are detailed from time to time in
the Company’s SEC filings, and could cause the actual results to
differ materially from those contained in any forward-looking
statements. These forward-looking statements are made only as of
the date indicated, and the Company undertakes no obligation to
update or revise the information contained in any forward-looking
statements, except as required under applicable law.
Investor Relations Contacts
For investor and media inquiries, please
contact:
Aesthetic Medical International Holdings Group
LimitedEmail: ir@pengai.com.cn
DLK Advisory Limited Tel: +852 2857 7101Email:
ir@dlkadvisory.com
Aesthetic Medical (NASDAQ:AIH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aesthetic Medical (NASDAQ:AIH)
Historical Stock Chart
From Apr 2023 to Apr 2024